A focused library comprising nine residues of the active site of P450cam monooxygenase resulting in ∼300 000 protein variants was screened for activity on diphenylmethane (DPM). The assay was based on the depletion of NADH by an in vitro reconstituted P450cam system in a 96-well scale. The throughput was increased by the parallel cultivation, purification and analysis of 20 variants per well (cluster screening). Thus ∼20 000 protein variants could be screened in summary of which five were found to transform DPM with a specific activity of up to 75% of the wild-type activity on D-camphor and a coupling rate of 7 -18%. One variant converting DPM to 4-hydroxydiphenylmethane (4HDPM) was subjected to site-directed mutagenesis and saturation mutagenesis, which revealed the particular importance of positions F87, Y96 and L244 for substrate selectivity and the possibility for further improvements of this variant. Moreover, a reduction in size of the amino acid at position 396 decreased specific activity dramatically but increased coupling and switched the main product formation from 4HDPM towards diphenylmethanol.
Introduction
P450 monooxygenases are a family of versatile biocatalysts widespread in all classes of life and are involved in the production of secondary metabolites or in the degradation of xenobiotics (Ortiz de Montellano, 2005) . Their capability to hydroxylate substrates at non-activated carbon atoms makes them interesting tools for the regio-and stereoselective oxygenation in the production of pharmaceuticals or high value fine chemicals (Julsing et al., 2008) .
The best characterised P450 is CYP101, the camphor 5-monooxygenase (P450cam) from the soil bacterium Pseudomonas putida, which served as a model for a general understanding of the P450 reaction mechanism (Poulos and Raag, 1992) . It catalyses the hydroxylation of (1R)-camphor to 5-exo-(1R)-hydroxycamphor (Gunsalus and Wagner, 1978) . The early availability of structural data (Poulos et al., 1987) laid the foundation for numerous site-directed mutagenesis studies dealing with the alteration of the enzyme's substrate specificity. A wide range of molecules was shown to be hydroxylated by P450cam mutants, from small compounds like ethane (Xu et al., 2005) , over the conversion of other sesquiterpenes like valencene (Sowden et al., 2005) up to the oxygenation of the large polycyclic aromatic hydrocarbon pyrene (England et al., 1998) . This versatility and the possibility to use the P450cam system in Escherichia coli as a whole-cell biocatalyst with cofactor recycling (Mouri et al., 2006) makes P450cam a useful tool for applications in the pharmaceutical industry. However, adaptation of the substrate specificity to the need of a specific process is timeconsuming and labour-intensive. Good examples for this effort are the engineering of P450cam for the conversion of ethane to ethanol (Xu et al., 2005) and for the oxidation of pentachlorobenzene (Xu et al., 2007) , respectively. In both cases, numerous mutants had to be characterised and crystal structures were obtained. An alternative approach for the development of biocatalysts is the use of directed evolution. Despite considerable progress in this field (Bershtein and Tawfik, 2008) , only two studies demonstrated the application of evolutionary strategies for the improvement of P450cam. The work of Joo et al. describes a colony-based directed screening towards variants accepting H 2 O 2 for the transformation of naphthalene; hydroxynaphthalenes were converted to detectable fluorescent products by a coexpressed peroxydase (Joo et al., 1999) . However, the characterisation of resulting variants showed no increased activity over the wild type (Matsuura et al., 2004) . Speight et al. examined the combined saturation mutagenesis of Y96 and F98 for variants accepting diphenylmethane (DPM) as a substrate by the use of an in vivo biotransformation system and GC/MS analyses (Speight et al., 2004) .
The reason for the small number of studies using directed evolution strategies for the improvement of P450cam may be attributed to the general low activity of monooxygenases and the necessity for the electron transport proteins putidoredoxin reductase (Pdr) and putidaredoxin (Pdx) transferring electrons from NADH to P450cam (Katagiri et al., 1968) . These characteristics contribute to serious difficulties in screenings, especially in the case of using an in vitro approach.
Nevertheless, to use the advantages of evolutionary methods and to be independent from substrates able to be converted to fluorescent or coloured products, we establish a new in vitro screening system for P450cam selecting variants by the activity on NADH. The foundation was provided by a focused library, substituting only residues of the active site with limited sets of amino acids individually chosen for that positions. As part of the screening system, the variants were purified by one-step His-tag affinity chromatography in the 96-well format, which allowed us the parallel analysis of 20 variants in one well. Our intention was the alteration of substrate specificity towards DPM, which is a structural element of many pharmaceuticals. The possibility of a regioselective hydroxylation of DPM derivatives could thus open new opportunities for the production of drugs.
Materials and methods

Materials
All chemicals were purchased from Sigma-Aldrich (St Louis, USA) or AppliChem (Darmstadt, Germany). Enzymes for DNA manipulation were obtained from Fermentas (St Leon-Rot, Germany), NEB (Ipswich, USA) and Finnzymes (Espo, Finland). Oligonucleotides were synthesised by Thermo Scientific (Ulm, Germany). For cloning and expression, the following bacterial strains were used: Escherichia coli DH10B (Invitrogen, Carlsbad, CA, USA), BL21(DE3) (Novagen, Darmstadt, Germany) and ArcticExpress(DE3) (Stratagene, La Jolla, CA, USA). The plasmids pET28a, pUC18 and pRSF-1b were obtained from Novagen. Sequencing reactions were carried out at the central facility of the University of Leipzig (Germany).
Cloning and site-directed mutagenesis
Pseudomonas putida PpG1 was purchased from the DSMZ (Braunschweig, Germany) and grown in D-camphor minimal medium (ATCC medium 973). Genomic DNA was prepared as described by Thotsaporn et al. (2004) and used as a template in a polymerase chain reaction (PCR). The gene camC coding for P450cam was amplified with primer P450cam_XbaI_s and P450cam_HindIII_a and ligated into pUC18. A second PCR with the primer pair P450cam_PX_S/P450cam_HisX_a was performed to provide a C-terminal 6ÂHis-tag. Simultaneously, the restriction sites were changed to PagI and XhoI, respectively, for proper insertion downstream of the ribosome binding site into pRSF-1b to generate pRSF-P450cam.
The gene camB coding for putidaredoxin (Pdx) was amplified with the primers pdx_NdeI_s and pdx_NotI_a and ligated into pET28a in frame with the coding region for an N-terminal 6ÂHis-tag provided by the vector to generate pET28a-Pdx. The gene camA coding for putidaredoxin reductase (Pdr) was amplified by PCR with primers pdr_NcoI_s and pdr_SacI_a and ligated into pET28a in frame with the coding region for a C-terminal 6ÂHis-tag provided by the vector to generate pET28a-Pdr. The sequences of all primers used for cloning are listed in Table I .
Site-directed mutageneses were carried out using the QuikChange kit from Stratagene according to the manufacturer's instructions. All oligonucleotides are listed in Table II . Plasmids derived from site-directed mutageneses as well as ligation products were transferred to E.coli DH10B by electroporation. To ensure the accuracy of the constructs and the insertion of mutations, the plasmids were checked by sequencing.
Expression and purification of P450cam, Pdr and Pdx
Strains for expression were cultivated in Luria -Bertani (LB) medium supplemented with 1% D-glucose and the appropriate antibiotics. For the cultivation of the plasmid strains E.coli BL21(DE3) pRSF-P450cam and E.coli BL21(DE3) pET28a-Pdx, 50 mg/l kanamycin was added and for the cultivation of E.coli ArcticExpress(DE3) pET28a-Pdr, 50 mg/l kanamycin and 20 mg/l gentamycin were added.
For the production of wild-type P450cam and the P450cam variants, cultures were grown at 378C to an optical density of 0.6 at 600 nm. Recombinant gene expression was induced with 0.1 mM IPTG and the respective strains were cultivated overnight at 308C. Strains for the production of electron transport proteins were cultivated in the same manner, but after induction with 1 mM IPTG, the cultivation temperatures were lowered to 138C for Pdr and to 258C for Pdx, respectively. The use of E.coli ArcticExpress(DE3) producing heat shock proteins from the psychrophilic bacterium Oleispira antarctica in combination with lower expression temperature was shown in preliminary tests to have a positive effect on the yield of soluble Pdr. The cells were collected by centrifugation and stored at -208C prior to use. All following steps were carried out at 48C or on ice. The frozen pellets were resuspended in binding buffer A (25 mM Tris -HCl pH 7.4, 0.5 M NaCl, 20 mM imidazole) and disrupted by sonification for 3 Â 1 min. Cell debris was removed by centrifugation for 1 h at 15 000g and the crude cell extract was applied to a 1 ml HisTrap HP column (GE Healthcare, Chalfont, Great Britan). The column was washed with 20 column volumes of binding buffer A. Proteins were eluted with 120 mM imidazole in binding buffer A. Purified proteins were stored in 50% (v/v) glycerol at 2208C. Concentrations of P450cam and variants were determined by CO difference spectra as described previously (Omura and Sato, 1964) . The concentration of Pdr was determined according to its absorbance at 455 nm (1 455nm ¼ 10.8 mM 21 cm
21
; Roome et al., 1983) . Pdx concentration was calculated with 1 415nm ¼ 11.1 mM 21 cm 21 (Gunsalus and Wagner, 1978) .
Focused library
Nine residues were selected according to their proximity to D-camphor in the crystal structure of P450cam ( pdb_ID: 1AKD; Schlichting et al., 1997) . Limited sets of three to six possible amino acid exchanges were defined for every of these positions. The library was obtained from c-LEcta (Leipzig, Germany) according to our specifications and ligated into the vector pRSF-1b after amplification with the primers P450cam_PX_S/P450cam_HisX_Vv (Table I) .
Saturation mutagenesis
An overlap extension PCR-based method was used for saturation mutagenesis of P450cam (Pogulis et al., 1996) . Sequences of the used complementary sense and antisense primers bearing the NNK triplet are listed in Table III . Two overlapping fragments using pRSF-P450cam as a template were generated combining the degenerated primers with the sequencing primers of pRSF-1b (Table III) . The PCR products were digested with DpnI to destroy the template DNA. In a second step, the whole gene was amplified by extension PCR with both fragments and the nested primer pair P450cam_PX_s/P450cam_HisX_Vv and reintroduced into the pRSF-1b vector.
Cluster screening by NADH depletion
The focused library was screened using the cluster screening approach (Greiner-Stoeffele and Struhalla, 2003) . Escherichia coli BL21(DE3) was transformed with the focused library and stored at 2808C as a stock culture with 20% (v/v) glycerol. Cultivation and recombinant protein production were performed in 96-well deep-well plates in LB-medium containing 50 mg/ml kanamycin and 1% (w/v) D-glucose. Stock suspension was added to medium to yield roughly 40 cfu/ml before distributing the solution to primary culture plates resulting in about 20 cfu/well. The plates were cultivated overnight at 308C and were used to generate stock plates. From each well of the primary culture plate, 10 ml was used to inoculate 1.2 ml of medium per well in the expression culture plates. Induction of recombinant gene expression with 0.1 mM IPTG was started after 3 h of cultivation at 308C. After continued cultivation overnight, the cells were harvested and stored at 2208C prior to use. For protein preparation, the deep-well plates were thawed on ice and the pellets were resuspended in 300 ml binding buffer B (25 mM Tris -HCl pH 7.4, 20 mM NaCl, 20 mM imidazole) supplemented with 0.5 mg/ml lysozyme and 0.05 mg/ml DNaseI. After 30 min incubation on ice, the plates were shock frozen three times with liquid nitrogen and thawed in a water bath at 378C. Cell debris was pelleted by centrifugation (30 min, 5000g, 48C). Two hundred microlitres of the supernatant of each well were transferred to the upper reservoirs of a 96-column array (Atoll, Weingarten, Germany) equipped with 50 ml chelating sepharose FF (GE Healthcare, Chalfont St Gilles, Great Britan), loaded with Ni 2þ and equilibrated with binding buffer B. The crude extract was applied with centrifugal force (200g, 48C) and washed three times with 200 ml binding buffer B. Purified protein was eluted twice with 65 ml 200 mM imidazole in binding buffer B and the elution fractions were combined. For the activity assay, 40 ml of eluate was added to 160 ml assay mixture in 96-well microplate wells containing final concentrations of 0.3 mM Pdr, 3.3 mM Pdx, 1 mM NADH and 50 mM Tris -HCl pH 7.4. The reaction was started by addition of 1 ml of 1 M DPM in ethanol. The assay was performed at 308C in a microplate reader (BMG fluorostar, BMG Labtech, Offenburg, Germany) for 30 min. Absorbance changes at 340 nm caused by the consumption of NADH were recorded.
To obtain relative units (U rel ), the mean activity of the surrounding wells was subtracted from the activity of the destination well. This difference was divided by the standard deviation of the activity of the whole plate. Only wells with U rel . 3 were defined as hits. Samples from the appropriate stock plate well were spread out onto agar plates. Subsequently, screening was performed on a single clone level to identify individual bacteria producing the active P450cam variants.
Saturation libraries were treated like the focused library, but single colony screening was performed right from the beginning on.
Determination of NADH turnover rates and coupling efficiency
P450cam variants were produced and purified. A Shimadzu UV-1800 visible spectrophotometer equipped with a temperature control unit was used to kinetically determine NADH consumption by measuring changes in the absorption at 340 nm. Turnover rates were calculated with 1 340nm ¼ 6.22 mM 21 cm 21 and were corrected by subtracting the autoxidation rate of the electron transport proteins. Assay mixtures contained 1 ml of 40 mM potassium phosphate buffer pH 7.4 Semi-rational P450cam variants active on diphenylmethane with 1 mM P450cam, 1 mM Pdr, 10 mM Pdx and 200 mM KCl. After incubation for 5 min at 308C, the reaction was started by addition of 1 ml 1 M DPM in ethanol and 350 mM NADH. When the reactions reached the equilibrium 10 ml of 20 mM, 2-naphtol was added as internal standard. Subsequently, products were extracted with 250 ml CHCl 3 , which was applied to a gas chromatograph GC-2010 (Shimadzu, Kyoto, Japan) equipped with a SE-52 capillary column (IVA Analysentechnik, Düsseldorf, Germany). The temperature profile used in the GC run was according to Bell et al. (2001) . The retention times were: DPM 3.8 min, diphenylmethanol (DPMOH) 6.1 min, 2-hydroxydiphenylmethane (2HDPM) 6.7 min and 4-hydroxydiphenylmethane (4HDPM) 7.7 min. Product amounts were quantified by a calibration plot. For this purpose, various known concentrations of the reference substances with internal standard were extracted from assay mixtures and were analysed chromatographically with GC. To exclude any conversion, NADH was omitted. Every point in the calibration plot was determined in triplicates.
Results and discussion
Composition of a specificity library
We decided to use the semi-rational approach of focused libraries encouraged by results comparing focused libraries directly with random mutagenesis, which revealed that the former were preferable for the alteration of substrate specificity, explained with the stronger effect of accumulated mutations in the active site in contrast to mutations scattered over the whole gene (Kelly et al., 2007; Lipovsek et al., 2007) . The focused library of P450cam comprised 9 of the 13 residues within a 5 Å distance around the bound camphor in the crystal structure of P450cam ( pdb_ID: 1AKD; Schlichting et al., 1997). The conserved residues G248 and T252 were dismissed because of their role in oxygen binding (Harris and Loew, 1994) . F98 and T185 were excluded arbitrarily to keep library complexity low. The active site of P450cam with the remaining nine residues selected for focused randomisation is shown in Fig. 1 . The theoretical number of variants by standard combinatorial saturation mutagenesis would amount to 20 9 ¼ 5.12 Â 10 11 variants. In order to reduce the library complexity, the number of possible amino acid substitutions for each position was decreased from 20 to a maximum of 6. The benefit of more focused libraries was shown earlier by the work of Reetz et al. They reduced the codon degeneracy in saturation mutagenesis from NNK to NDT, resulting in less screening effort for the same percentage of library coverage and an adaptable amino acid alphabet excluding similar amino acids and without over-representation of certain residues (Reetz et al., 2008) . Unlike that the provided library allowed for every position the free selection of residues available for substitution independent from the genetic code. The exchange sets were not defined rational, but by means of the existing natural diversity at the corresponding positions in the 10 most similar protein sequences found with the BLAST algorithm (Altschul et al., 1990) and aligned with the BLOSUM 62 scoring matrix (Henikoff and Henikoff, 1992) . The most frequent residues at the corresponding positions in the alignment including the wild-type residue were selected as shown in Table IV . This resulted in a library containing 291 600 possible variants. Ten randomly selected variants of the provided library were sequenced confirming the correct preparation according to the defined specifications.
Development of an in vitro assay for cluster screening of P450cam
The cluster screening (Greiner-Stoeffele and Struhalla, 2003) increases the throughput of the screening assay by the partial uncoupling of phenotype and genotype. Instead of performing the screening on a single clone level, the cluster screening approach uses the screening of whole mixtures of clones with unknown identity (cluster). In subsequent steps, positive candidates are isolated by breaking the cluster down to the single clone level. The signal-to-noise ratio defines the possible complexity of a cluster and therefore the throughput of the assay.
The activity of His-tag purified Pdr and Pdx with crude extracts of P450cam was shown to be disturbed by the background of the production host E.coli. Hence an immobilised Ni 2þ ion affinity chromatography via His-tag was included into the screening protocol. The one-step purification was carried out in a 96-column array, yielding a single band of P450cam on a SDS -PAGE gel (Fig. 2) . The parallel cultivation of different variants in one well reduces the signal of a positive variant to a fraction corresponding to the number of different clones in that well. To determine the maximum number of parallel clones, P450cam purified with the 96-column array was differently diluted with eluate obtained from an identical purification run with E.coli BL21(DE3) with empty pRSF-1b. The assay was performed showing that up to a dilution of 1:100, P450cam was still traceable (Fig. 3) . That meant that one positive variant can be detected out of 99 inactive variants. Yet, the size of a cluster was set to 20 instead of 100 to allow also the detection of less active variants.
Library screening
Altogether 19 200 variants were screened for activity on the substrate DPM. Five clusters reached the threshold of U rel . 3 and thus were defined as initial hits. They were broken down to the single clone level and subjected to a second round of screening. The screening of one deep-well plate and the disassembly of the active cluster is exemplarily shown in Fig. 4 . The reduction of signal intensity by the dilution with inactive variants in the cluster compared with the signal of the isolated active variant is obvious.
In this way, five different variants of P450cam were isolated, corresponding to a hit rate of one DPM-converting hit in about 4000 variants. The mutation pattern as well as the specific activities of the DPM-converting variants, their coupling efficiency and their product distribution compared with the wildtype enzyme are presented in Table V . Fowler et al. stated that P450cam has no activity on DPM. In accordance with that, we could find almost no wild-type activity on DPM (Fowler et al., 1994) . In our experimental setup, the activity of the wild-type P450cam towards its natural substrate . The resulting enzyme variants showed an activity on DPM of 28-75% relative to the wild-type activity on D-camphor. The coupling efficiency for the substrate DPM was diminished in all variants compared with the 95% coupling rate of P450cam on camphor (Atkins and Sligar, 1988) . The fact that the isolated variants were highly active, but used only a low portion of NADH for the conversion of DPM satisfied the first law of directed evolution 'you get what you screen for' (You and Arnold, 1996) since solely the rate of NADH consumption was used as a measure for the identification of active P450cam variants. The variants P450cam-Y96A and P450cam-Y96F/I396G presented earlier (Bell et al., 2001 ) had a coupling efficiency in the same range as determined for our variants. In contrast to Fig. 3 . Determination of the maximum clone number per well which still permitted the detection of one comprised active variant in a cluster of variants. Different amounts of purified P450cam were diluted in purification column eluat obtained from the cultivated control strain E.coli Bl21(DE3) with empty plasmid pRSF-1b as indicated. The mixtures were assayed measuring the NADH depletion at 340 nm.
Semi-rational P450cam variants active on diphenylmethane that, the specific activity of the most productive variant 6h1h10 (Table V) was nearly 6-fold, respectively, and 4-fold higher.
The observed hydroxylation products of DPM were identified as 4HDPM, 2HDPM and DPMOH by comparison with reference substances. No reference substance for the fourth possible product 3-hydroxydiphenylmethane, which is hydroxylated at the meta-position, was available. Since there were no other peaks besides the aforementioned allocated to 4HDPM, 2HDPM and DPMOH, it can be safely assumed that 3-hydroxydiphenylmethane was not formed by the characterised variants. The main product of all variants was 4HDPM fluctuating in a range of 61 -100%. The best variant 6h1h10 measured by the product forming rate converts DPM exclusively to 4HDPM. The DPM mutants presented earlier were also described to produce 4HDPM as a sole product (Bell et al., 2001) .
In all mutants, at least six of the nine mutant positions were changed to non-wild-type amino acid residues. But also simultaneous exchanges at all nine positions (variant 8f9e2) lead to active variants, emphasising the flexibility of the P450cam active site. Noticeably, at positions F87, Y96 and L244, nearly all active variants exhibit Ile, Met and Asn, respectively, whereas at the other positions, more variability was observed. This underlines the influence of position F87, Y96 and L244 on substrate specificity of P450cam. All three residues are involved in substrate binding, whereby Y96 forms a hydrogen bond to the carbonyl oxygen of camphor (Poulos et al., 1987) . Single mutations of Y96 were shown to enable binding and transformation of unnatural substrates, e.g. the conversion of phenanthrene (Harford-Cross et al., 2000) or even the conversion of DPM (Fowler et al., 1994) . Also the work of Speight et al. underlines the role of Y96 in DPM hydroxylation obtaining P450cam-Y96A as the best variant in the screening for 4HDPM production in the simultaneous saturation of Y96 and F98 (Speight et al., 2004) . Y96, as part of the substrate access channel (Dunn et al., 2001) , was subjected to mutations in almost all published studies of P450cam dealing with alterations of its substrate specificity (e.g. England et al., 1998; Bell et al., 2001 Bell et al., , 2003a Sowden et al., 2005) . The incorporation of mutations at position L244 generally occurred only in order to improve existing variants, e.g. for the conversion of pentachlorobenzene (Chen et al., 2002) or the hydroxylation of indole to form indigo (Manna and Mazumdar, 2010) . The relevance of F87, Y96 and L244 derived from the mutation pattern of our mutants and from the results of published variants raised the question if also mutations at positions with more variability contribute to an improvement of DPM-converting activity.
Rational engineering on variant 5A6B3
To determine the contribution of every single mutation exemplarily for one variant, the 6-fold mutant 5a6b3 was chosen. This P450cam variant has the lowest activity on DPM among all variants analysed, which points to the existence of unfavourable mutations. Six variants were generated restoring separately the wild-type residues at every previously altered position. The results are shown in Table VI . Interestingly, only the variant 5a6b3-297D with the mutation T297D shows a slightly improved product formation rate by an increase in coupling efficiency. All other variants exhibit a decrease in the conversion of DPM. This effect is more pronounced for variants with the mutations V87F, M96Y and N244L. Possibly, in these variants, the exchanged amino acid residues are more bulky and less flexible and thus block the voluminous substrate DPM from entering the active site. It seems likely that the concentration on variants with the highest activities alleviated the finding of variants with partially disadvantageous mutations. In the case of the M395I mutation, the increase in NADH turnover rate is annihilated by the decreased coupling efficiency. We suppose that the unbranched side chain of I395M in 5a6b3 lies in the same tangential direction relative to the active site as the main side chain of I395 in the wild type. The recovery of Ile at position 395 in 5a6b3 -M395I reduces coupling possibly by the methyl group at the beta C-atom of I395 pointing towards the active site thus negatively influencing the mode of binding. The presence of wild-type residues also changes the variety of the formed products in some variants, e.g. 5a6b3 -396V. Possibly, the size reduction at position 396 by I396V permits the movement of DPM towards V396 and brings the ortho-carbon atom closer to the central iron atom leading to an increased fraction of 2HDPM. To test whether a further decrease in size of amino acid residues at position 396 would enhance this effect, the variants 5a6b3 -I396A and -I396G were generated and analysed (Table VI) . Already the introduction of Ala at position 396 changed the product spectrum towards DPMOH as the main product. 2HDPM was still formed, but its fraction was decreased. Introduction of Gly at position 396 further increased this tendency. No 2HDPM was formed at all and the 4HDPM/ DPMOH-ratio was shifted even further towards DPMOH.
The replacement of I396 in variant 5a6b3 by smaller residues suggests a movement of one phenyl ring into the liberated space diagonal above the iron atom of the haeme. This requires a turning of the flexed DPM, which brings the methylene carbon in a reactive position. The need for rotation of DPM during entrance to the active site and binding in cross position may be the reason for the reduced activity.
Saturation mutagenesis at positions 96 and 244 of variant 5a6b3
The results underline the importance of mutations at positions 87, 96 and 244 for the DPM-converting ability of variant 5a6b3. In contrast to position 87 where the set of amino acids in the library comprised the two aromatic amino acids Trp and Phe as well as aliphatic amino acids of different chain length, the sets of possible amino acids at positions 96 and 244 were less variable. The design of the library permitted only hydrophilic amino acid residues (except Trp) at position 96 whereas the amino acids Leu, Gln and Asn were chosen as possible residues at position 244.
As a consequence, in the next step, we wanted to evaluate the possibility for further improvements of variant 5a6b3, in the case of using the full set of all 20 possible amino acids at these positions. This was tested by two independent saturation mutageneses at positions 96 and 244 by NNK codon degeneracy. For both positions, 184 clones were screened with the screening system based on NADH depletion. Approximately one-quarter of the clones had a considerable activity on DPM. The two best variants resulting from the screening procedure saturated at position 244 were 5a6b3 -N244T and -N244P. The analysis revealed that these variants had no improved activity compared with 5a6b3 (Table VII) , although their activity in the screening was higher than that of 5a6b3 used as a control on the same screening plates. The relative units (see above) considering the mean of the activities of the surrounding wells gave 4.9 and 3.4 for 5a6b3 -N244T, respectively, and -N244P in contrast to 0.9 for 5a6b3. Hence, it seemed that the screening system is inapplicable for the semi-quantitative evaluation of variants, when they are all active on the substrate. The appearance of N244P was surprising, since position 244 is part of helix I. Proline known as an alpha-helix breaker causes a kink when occurring in alpha-helices (Barlow and Thornton, 1988) which may induce a change in the backbone structure of variant 5a6b3 -N244P resulting in a decrease of coupling. Since helix I comprises the catalytic active residue T252 (Harris and Loew, 1994) , this possibly affects oxygen binding, but without structural methods, all changes in the structure of the active site remain uncertain.
Despite the problem that the screening system was disadvantageous to achieve quantitative results, the saturation on Data are given as mean + standard derivation with n ! 3. The percentage of NADH used for product formation.
Semi-rational P450cam variants active on diphenylmethane position 96 yielded variant 5a6b3 -M96F with a 42% higher specific activity and a slightly improved coupling compared with the initial variant 5a6b3 (Table VII) . M96F may enhance activity and coupling by reducing the active site volume and by aromatic interaction with the second phenyl moiety of DPM. Bell et al. engineered variant P450cam-Y96F-I395G active on DPM assumed that one phenyl ring of DPM is accommodated by the space liberated by the I395G mutation and interacts with the neighbouring F87 (Bell et al., 2001) . Similar to that Speight et al. found the variant P450cam-Y96F-F98G also able to hydroxylate DPM which shows the possibility for different arrangements of DPM in the active site, all facilitating the production of 4HDPM (Speight et al., 2004 ). This could not be transferred directly, but in 5a6b3 -M96F, the role of I396G or F98G maybe substituted by the I395M/F87V mutation creating space for one phenyl ring which then interacts with M96F. However, the variant 5a6b3 -M96F proved the possibility for further improvements of the focused library variants by the identification of key positions for activity and overcoming of the exchange set constraints.
Conclusion
The DPM-converting variants presented here comprising six to nine mutations demonstrate the flexibility of the P450 fold. The discovery of variant 6h1h10 active on DPM with 75% of the wild-type activity towards camphor proves the effectiveness of the focused library conception. In contrast to iterative methods like site-directed mutagenesis, the major advantage of this approach is the concomitance of mutations at all selected positions enabling the virtue of synergistic effects. This leads to mutation patterns, inaccessible by other methods, which themselves could be new starting points for further site-directed mutageneses or saturation mutageneses approaches. The altered regioselectivity of variants 5a6b3 -I396A and -I396G, changing the main product from 4HDPM towards DPMOH, demonstrates one direction for further improvements of the redesigned active site of P450cam even if the specific activity of this variants decreased drastically.
